Skip to main content
# Title Department Research Member Research Year
381 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Department of Medical Oncology Yasmine Ali Roshdy 2020
382 Radiofrequency thoracic sympathectomy for sympathetically maintained chronic postmastectomy pain, a Preliminary Report:6 Month Results Department of Anesthesia, Intensive care and Pain management Dr. Mohammed Moamen Abdelnaeem Tawfeek 2020
383 Neutropenic enterocolitis in pediatric leukemia patients treated with intensive chemotherapy in Upper Egypt Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2020
384 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience)
Department of Pathology Dr. Shimaa Hassan Shabaan Hassan 2020
385 Predictors of satisfactory outcome following repair of postcholecystectomy bile duct injury Department of Surgical Oncology Mohamed Ismail Omar Ali 2020
386 Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial Department of Anesthesia, Intensive care and Pain management Dr. Amira Mahmoud Mohammed Osman 2020
387 3. Pulsed Radiofrequency on Thoracic Dorsal Root
Ganglion Versus Thoracic Paravertebral Nerve
for Chronic Postmastectomy Pain, A Randomized
Trial:6-MonthResults

Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2020
388 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2020
389 3. Pulsed Radiofrequency on Thoracic Dorsal Root
Ganglion Versus Thoracic Paravertebral Nerve
for Chronic Postmastectomy Pain, A Randomized
Trial:6-MonthResults

Department of Anesthesia, Intensive care and Pain management Dr. Diab Fuad Hetta 2020
390 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Department of Medical Oncology Dr. Abeer Elsayed Ali Ibrahim 2020